BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HDM2020 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HDM2020\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07638891-2511@assetmemo.bio
DTSTAMP:20261121T005335Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:HDM2020: Phase 1 readout est. (NCT07638891)
DESCRIPTION:HDM2020\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study
  of HDM2020 in Patients With Advanced Sq-NSCLC\nEstimated primary completi
 on: 31 January 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 hdm2020#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07638891
URL:https://assetmemo.bio/drug/hdm2020#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
